To admire is a form of exposure. The moment we declare our fascination, we disclose the private coordinates of taste and longing: what we find desirable, what we forgive, what we wish to be.
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback